Distinct Trajectories of Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Survivors Treated With R-CHOP

Healthcare providers should closely monitor older patients, those with pretreatment peripheral neuropathy symptoms, and those exhibiting pronounced sensory neuropathy during treatment to provide timely and effective symptom management, reducing the impact of CIPN.